Trials / Completed
CompletedNCT01256437
Evaluating Preventive Therapy With Oint Threolone, Synthomycine or Aqua Cream, for EGFR'I Induced Acneiform Rash
Double Blind Placebo Controlled Trial, for Evaluating Preventive Therapy With Either Oint Threolone Versus Synthomycine Versus Aqua Cream, for EGFR'I Induced Acneiform Rash
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Rabin Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigators hypothesized that topical anti-inflammatory treatment could counteract the inflammatory reaction induced by EGFR'Is.
Detailed description
The investigators hypothesized that topical anti-inflammatory treatment could counteract the inflammatory reaction induced by EGFR'Is.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Threolone ointment | ointment once daily for 1 month |
| DRUG | ointment Synthomycine | ointment once daily for 1 month |
| DRUG | Aqua cream | ointment once daily for 1 month |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2017-01-01
- Completion
- 2017-03-01
- First posted
- 2010-12-08
- Last updated
- 2017-05-09
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01256437. Inclusion in this directory is not an endorsement.